Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DERIVO Embolization Device Study: Monotherapy vs Dual Antiplatelet Therapy
NCT06400940Phase 4Recruiting
- Start
- Aug 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor, prasugrel in intracranial aneurysm. Started Aug 2023; status: recruiting.
02
Drugs
ticagrelorprasugrel
03
Conditions
intracranial aneurysm
Beyond the preview
Go deeper on NCT06400940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400940.